Researchers found that ArfGAP2 appears to play a key role in both normal immune responses and harmful overactivity.

An experimental treatment appears to postpone Alzheimer's symptoms in some people genetically destined to get the disease at ...

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

Scientists are trying to tackle Alzheimer's from all angles, and a new study adds to the growing evidence that semaglutide, a ...

While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...

Leqembi is an infusion therapy that targets and removes the beta-amyloid plaque that builds up in the brains of Alzheimer's patients.

The delays in Alzheimer’s research is one example of how millions of dollars in research have been stalled as NIH grapples ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

An experimental Alzheimer's treatment from Boston researchers may be able to treat both dementia and depression symptoms.